Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jubilant Ingrevia is a global integrated life science products and innovative solutions provider, serving the pharmaceutical, nutrition, agrochemical, and consumer sectors. Spun off from Jubilant Life Sciences in 2021, the company operates through three main segments: Specialty Intermediates, Nutrition & Health Solutions, and Life Science Chemicals. It is a world leader in pyridine and picolines and is one of the largest producers of Vitamin B3 (Niacinamide and Niacin) globally. As a CDMO, Jubilant Ingrevia provides custom synthesis and manufacturing services for complex small molecule intermediates used in highly regulated markets. The company maintains a strong manufacturing footprint in India and serves a diverse global clientele across more than 60 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ingrevia.